81 results on '"Fayon, M."'
Search Results
2. 168 A pan-European perspective: guidance for the use of chest CT in children and adults with cystic fibrosis.
3. 146 Standardizing European imaging practice: European Cystic Fibrosis Society—Clinical Trial Network Imaging Special Interest Groups
4. WS11.05 Scanning the landscape: ECFS Clinical Trial Network: CT imaging monitoring strategies.
5. P247 Improved quality of care increases lung function and growth parameters in children with cystic fibrosis
6. P155 Pharmacokinetic of aminoglycosides in children with cystic fibrosis
7. WS03.4 Lumacaftor/ivacaftor improves the intestinal inflammation in children with cystic fibrosis
8. P412 Patient and parent perception regarding clinical research in south-west France
9. P052 Late impact of early chronic methicillin-sensitive Staphylococcus aureus (MSSA) infection in children with cystic fibrosis
10. P025 Lumacaftor/ivacaftor in real life for Phe508del homozygous, adolescents with severe and normal lung function
11. 314 Intake of liposoluble vitamins from food and vitamin supplementation in children with CF
12. 263 Improvement of quality of care: the Phare-M program in Bordeaux paediatric CF centre
13. EPS6.2 Feasibility of telehomecare (THC) in children with cystic fibrosis (CF)
14. Évaluation multicentrique et randomisée de l'impact des conseillers en environnement intérieur sur le contrôle de l'asthme : l'étude ECENVIR.
15. ePS06.5 Post-hoc review of outcomes in patients switching from tobramycin for nebulization solution (TNS) to aztreonam lysine for inhalation (AZLI)
16. 296 The French clinical trials network: The National Platform for Clinical Research (NPCR)
17. 110 Aztreonam for inhalation solution (AZLI) for eradication of new onset Pseudomonas aeruginosa (PA) infection in children with cystic fibrosis (CF): Evaluation of treatment failures
18. WS02.2 Aztreonam for inhalation solution (AZLI) for eradication of new onset Pseudomonas aeruginosa (PA) infection in children with cystic fibrosis (CF): Results of facemask vs. nebulizer mouthpiece use
19. Alternatives à la corticothérapie inhalée dans le traitement de l’asthme de l’enfant : les anti-leucotriènes.
20. Consensus national sur les modalités de prescription des corticoïdes inhalés dans la mucoviscidose.
21. 285 Comprehensive management of senso-motor disorders of orality in paediatric CF patients
22. 82 Secondary prophylactic antibiotics against Staphylococcus aureus (Sa) during the winter months in children with cystic fibrosis
23. Événements néonataux et asthme.
24. Trachéobronchomalacie de l’enfant : de l’abstention à l’interventionnel
25. La corticothérapie dans la vie du nouveau-né prématuré
26. 182 Exhaled breath condensate (EBC) oxidative stress in children with cystic fibrosis
27. P058 LUNG MEMBRANE DIFFUSION AND CAPILLARY VOLUME IN CROHN'S DISEASE: A PILOT STUDY
28. Neonatal CF screening (2003–2008) in the Aquitaine region in France: high probability of a second CFTR gene mutation in heterozygotes with subnormal sweat tests
29. 337 Feasibility and tolerance of percutaneous central catheters in children with cystic fibrosis (CF)
30. Atteinte respiratoire précoce dans la mucoviscidose.
31. La sécrétion accrue de « leukaemia inhibitory factor » par les cellules musculaires lisses immatures des voies aériennes augmente la signalisation calcique intracellulaire
32. Évaluation de la prescription des plans d’actions d’asthme par les médecins d’Aquitaine.
33. Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation.
34. Comparative study of high frequency percussive ventilation, high frequency ventilation by oscillation and conventional ventilation in a piglet model of meconium aspiration.
35. Histological analysis of lung biopsies and airway smooth muscle cell culture.
36. Lung capillary blood volume and membrane diffusing capacity in children with inflammatory bowel disease.
37. Pulmonary outcome at school age for children born with a gestational age less than 32 weeks.
38. Mechanisms of enhanced proliferation of cultured immature airway smooth muscle (ASMC).
39. L2/100 – Increased secretion of leukaemia inhibitory factor by immature airway smooth muscle cells enhances intracellular signalling and airway contractility.
40. C4/263 – Screening for alpha1-antitrypsin deficiency (a1-ATd) in childhood asthma may be beneficial.
41. CF-Emerging therapies: Modulation inflammation.
42. Recherche en pédiatrie (2) : le consentement en pratique.
43. Recherche en pédiatrie (1) : dispositions juridiques relatives au consentement.
44. P019 Chest computed tomography imaging practices of people with cystic fibrosis: insights from radiologists, radiographers, and pulmonologists.
45. Nouvelles thérapeutiques ciblant le canal chlorure dans la mucoviscidose.
46. Éditorial.
47. SFP-P158 – Hépatologie, gastro-entérologie et nutrition – Diffusion membranaire et volume capillaire pulmonaire dans la maladie de Crohn
48. Epidémiologie virale et sévérité clinique pendant le pic d’épidémie grippale A(H1N1) variant dans les atteintes respiratoires fébriles de l’enfant.
49. Recommandations sur l’utilisation des nouveaux outils diagnostiques étiologiques des infections respiratoires basses de l’enfant de plus de trois mois.
50. Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.